date:Jun 17, 2014
Dyadic International, Inc. (Dyadic) (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today the appointment of Michael Tarnok to the company's Board of Directors. Mr. Tarnok will also serve on the company's audit and compensation committees.
Mr. Tarnok has extensive experience in the pharmaceutical industry across many key areas including finance, operations and marketing. He is the current Chairma